Chris Hibberd
CEO Nucleix
- Role
- Board Member at MeMed
- Location
- San Diego, CA, US
- LinkedIn followers
- 500 followers
About Chris Hibberd
CEO and Co-Founder, a proven team builder and a skilled negotiator, with over 20 years of experience in working with brilliant teams to identify, create and build high value medical device products and biotech discovery technologies. Co-Founded and built Astute Medical, a world class medical technology discovery and diagnostic company. Built an impressive team, secured VC funding, negotiated debt financing, built a product pipeline, launched the 1st FDA cleared product for Acute Kidney Injury risk and negotiated numerous global collaborations. One of the collaborators, bioMérieux, acquired Astute Medical in April 2018.Prior to Biosite\'s $1.7B acquisition in 2007, led a productive business development and strategic planning group and co-founded Biosite Discovery to leverage a world class antibody capability.
Experience
Board Member
Nov 2020 — Present
MeMed\'s mission is to translate the complex signals of the immune system into simple diagnostic insights that transform the way we treat infectious diseases and inflammatory disorders – at the right place and the right time.
Education
Western University
Master of Business Administration (MBA)
1990 — 1992
Association of Professional Engineers of Ontario
P.Eng.
1990
Rotterdam School of Management, Erasmus University
MBA, International Exchange Program
1991 — 1991
University of Toronto
Bachelor of Applied Science (B.A.Sc.), Chemical Engineering
1983 — 1987
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.